The goal of this program is to provide updates on the management of melanoma, colorectal cancer, renal cell carcinoma, bladder cancer, and testicular cancer, and metastatic breast cancer. After hearing and assimilating this program, the clinician will be better able to: 1. Select evolving neoadjuvant therapies for resectable, high-risk melanoma. 2. Choose immunotherapy rather than chemotherapy for treatment of metastatic colorectal cancer. 3. Use circulating tumor DNA for the management of colon cancer. 4. Recognize the potential of kidney injury molecule-1 as a key marker in renal cell carcinoma. 5. Determine whether a patient with advanced breast cancer is likely to respond to fulvestrant.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2024-11-13 06:00:00
- End Date: 2024-11-13 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- MOC Credit Details: ABIM - 2.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest